Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Single-nucleotide mutation rate increases close to insertions/deletions in eukaryotes.
Surgical complications in patients with head and neck cancer receiving chemotherapy.
Should children and adolescents undergo genetic testing?
Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia.
Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4 Suppl 2):502-8.
View in:
PubMed
subject areas
Chlorambucil
Follow-Up Studies
Humans
Leukemia, Hairy Cell
Leukopenia
Splenectomy
authors with profiles
James W. Vardiman